Showing results (191-200 of 313) with videos related to
Sort By:
Pageof 32
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 25, 2013
Parkin mutation and deep brain stimulation outcomeHee Jin Kim, Ji Young Yun, Young-Eun Kim, et al.Plos One|January 26, 2021
Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s diseaseKwang Hyon Park, Sukkyu Sun, Yong Hoon Lim, et al.Clinical Proteomics|October 24, 2023
Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkersNarae Kang, Hyun Jeong Oh, Ji Hye Hong, et al.Journal of Clinical Medicine|September 24, 2020
Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center ExperienceHye Ran Park, Yong Hoon Lim, Eun Jin Song, et al.International Journal of Radiation Oncology, Biology, Physics|December 2, 2008
Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohortsDavid W Andrews, Maria Werner-Wasik, Robert B Den, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 3, 2014
Rapid eye movement sleep behavior disorder after bilateral subthalamic stimulation in Parkinson's diseaseYoung Eun Kim, Beom S Jeon, Sun-Ha Paek, et al.Molecular Cancer Therapeutics|January 8, 2017
Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3RSeokmin Kang, Jinpyo Hong, Jung Moo Lee, et al.Journal of Movement Disorders|July 26, 2022
Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related DystoniaKyung Ah Woo, Han-Joon Kim, Seung-Ho Jeon, et al.American Journal of Cancer Research|July 10, 2023
THOC2 expression and its impact on 5-fluorouracil resistance in glioblastoma multiformeYoung Jun Lee, Jin-Hwa Jung, Da-Young Chang, et al.Mitochondrion|June 14, 2011
The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cellsJung Hee Shim, Seung Hee Yoon, Kyung-Hee Kim, et al.Pageof 32